Globally, the researchers found that more than 7,40,000 or four per cent of new cancer cases in 2020 may be attributed to alcohol drinking.
'Scientific data has proven that masks can reduce COVID-91 transmission by 53 per cent...A booster dose of vaccine, even if it works, is just a temporary fix'
The industrialised world must work fast.
Poonawalla, during an interaction with Odisha Chief Minister Naveen Patnaik through a video conference, expressed optimism that the COVID-19 vaccine could be ready by October-November this year and the next phase of the trial can start in mid-August in India. According to a press note released by the CMO, Poonawalla has informed that the Oxford University vaccine has shown promising results in the first phase trial.
The researchers noted that transmission rates of SARS-CoV-2 are much higher indoors than outdoors, and transmission is greatly reduced by indoor ventilation.
The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.
'A setback in UP will be nothing short of a political disaster on the eve of the 2024 general election.' 'Will it mean that Modi will be able to stay in his new house only for a year after it becomes ready?' asks Amulya Ganguli.
The remarks come amid suspected cases of COVID-19 reinfection being reported from abroad and from Indian states like Telangana, Karnataka, Gujarat, Punjab and Maharashtra.
Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and 'killer T-cells', a senior source from the trial was quoted by The Daily Telegraph as saying.
WHO director-general Tedros Adhanom Ghebreyesus said that in view of a paper published last week in the Lancet medical journal, that showed people taking hydroxychloroquine were at higher risk of death and heart problems than those that were not.
'A good 30 per cent of people will still get infected after getting the Covishield vaccine.'
The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready. Trials results for the first two phases were published earlier this month.
As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.
According to a Lancet study an estimated 15.6 million abortions took place in India in 2015, of which about half of the pregnancies were unintended.
The researchers said 5.6 per cent of the children assessed in the studies suffered from co-infections, such as flu, on top of COVID-19, and a little more than 3 per cent were admitted to intensive care units.
'Serial testing is much more valuable than a single test which reflects just a point in time.'
The deadly new strain of bird flu that has killed 36 people in China has developed resistance to antiviral drugs in some patients, scientists say.
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.
The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors -- recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).
'Your body will be able to deal with Omicron at any time, but it depends (on when) if you are vaccinated.'
According to the findings of the phase 1/2 randomised clinical trial, published in The Lancet Infectious Diseases journal, the vaccine candidate could induce an antibody response in participants within 28 days of the first immunisation, by giving two doses 14 days apart.
It has always been perceived that cancer is generally restricted to the more affluent class in comparison with the poorer people. This is a myth and a recent report in Lancet has busted it. Sriram Balasubramanian reports.
Several companies and technology heavyweights including Microsoft, Oracle and Salesforce are working to create a digital vaccination passport or health passport app in the hope that governments and airlines will require travellers to upload details of their Covid-19 tests and immunisation. The vaccine passport will effectively create digital credentials that could be the key to attending crowded events or even visiting countries.
Physical inactivity causes about six to 10 per cent of major non-communicable diseases, including coronary heart disease and type 2 diabetes, and kills around 5.3 million people a year, a new study has claimed.
The results show they induced strong antibody and T-cell immune responses for up to 56 days after they were given. T-cells are crucial for maintaining protection against the virus for years.
'Between its natural immunity with Delta, in so many populations, and then getting on top of the vaccination (situation), I do not think India is going to have another bad wave.'
'If you want to protect yourself just maintain good hygiene, wash your hands often and try not to touch your face, your mouth or nose without cleaning first'
Malaria kills more than 200,000 people in India every year, nearly 13 times higher than a 'misleadingly low' World Health Organisation estimate, a new study has claimed, but the United Nations body disputed the finding.
A team of experts has, in fact, tracked the enzyme in Britain, India, Pakistan and Bangladesh and believes it to be more widespread than first thought. It is said to be resistant even to a class of antibiotics known as carbapenems, which are reserved for use in emergencies and used when bacteria are found to be resistant to more commonly prescribed antibiotics.
Chief Minister Sheila Dikshit on Monday appealed to people in the city not to panic in the wake of reports that a drug resistant bacteria had been found in Delhi's public water supply. The Delhi Jal Board had rejected the findings of international scientific journal Lancet, she said. "The Delhi Jal Board has very categorically said that this is not the case. I am in touch with the CEO and he said that it is not so. So please don't spread panic," she said.
Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.
As the coronavirus outbreak enters its fifth month, the UN Children's Fund (UNICEF) requested $1.6 billion to support its humanitarian response for children impacted by the pandemic. The health crisis is 'quickly becoming a child rights crisis. And without urgent action, a further 6,000 under-fives could die each day', it said.
The study noted that nine of 30 large states -- Madhya Pradesh, Bihar and Telangana, Jharkhand, Uttar Pradesh, Maharashtra, West Bengal, Odisha, and Gujarat -- have high vulnerability to be impacted by the COVID-19 pandemic.
'I don't think anybody would want to be in my position today where every head of State has to be explained that I am prioritising my country because there is a surge in cases.'
'One thing we have learnt is that a pandemic can be arrested at any stage.' 'Not suddenly, of course, but slowly with steady unwavering focus.'
Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five United Kingdom hospitals in April and May as part of the phase one clinical trial.
Life expectancy will be higher for both men and women.
Researchers at London School of Hygiene and Tropical Medicine and Oxford University headed the study to examine the possibility that health might suffer as a result of the market crashes. Lead author David Stuckler estimated that increased stress stemming from job losses could prompt a 2.4 per cent rise in suicide rates. Another 2.7 per cent rise in heart attack deaths could be expected, along with a 2.4 per cent increase in homicides rates.
Pune's Serum Institute of India, the world's largest vaccine maker by volume, is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222 with CEO Adar Poonawalla stating he would start manufacturing at personal risk.
'...of the non-availability of doctor expertise or appropriate treatment.' 'That's because of the nature of the disease at this point of time, it is very difficult to contain.'
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances